Hybrid Conferencee

International Summit on Organoid Research and Stem Cell Therapies (ISORST - 26)

6th - 7th October 2026 | New York, USA

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in New York. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the New York event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the New York conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in New York, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in New York."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Organoid Technology

This track will explore the latest innovations in organoid technology, focusing on the development of new methodologies for organoid generation and maintenance. Researchers will present their findings on how these advancements can enhance the fidelity and applicability of organoids in various research contexts.

Track 02

Organoids in Disease Modeling

This session will delve into the application of organoids as models for studying complex diseases, including cancer, neurodegenerative disorders, and infectious diseases. Presenters will discuss how organoid models can replicate disease pathology and facilitate drug discovery.

Track 03

Stem Cell-Derived Organoids

This track will focus on the derivation of organoids from stem cells, emphasizing the potential of pluripotent and adult stem cells in organoid research. Discussions will include the challenges and successes in generating organoids that accurately reflect in vivo tissue architecture.

Track 04

Regenerative Medicine Applications

This session will highlight the role of organoids in regenerative medicine, showcasing their potential in tissue repair and replacement strategies. Researchers will present case studies where organoids have been utilized to advance therapeutic approaches.

Track 05

Translational Research and Clinical Applications

This track will address the translational aspects of organoid research, focusing on how findings can be effectively moved from the laboratory to clinical settings. Participants will discuss successful case studies and the regulatory challenges faced in this transition.

Track 06

Organoids in Precision Medicine

This session will explore the integration of organoid technology in precision medicine, particularly in tailoring treatments to individual patient profiles. Presentations will cover the use of patient-derived organoids to predict therapeutic responses.

Track 07

Ethical Considerations in Organoid Research

This track will engage in discussions surrounding the ethical implications of organoid research, including issues related to consent, ownership, and the potential for organoid-derived therapies. Experts will provide insights into the ethical frameworks guiding this rapidly evolving field.

Track 08

Tissue Engineering and Organoids

This session will examine the intersection of tissue engineering and organoid technology, focusing on how engineered scaffolds can support organoid growth and functionality. Researchers will present innovative approaches to enhance organoid viability and integration.

Track 09

Organoids for Drug Screening and Toxicology

This track will investigate the use of organoids in drug screening and toxicology assessments, highlighting their advantages over traditional models. Presenters will discuss how organoids can provide more relevant biological responses in preclinical testing.

Track 10

Biomarkers and Organoid Research

This session will focus on the identification and validation of biomarkers derived from organoid studies, emphasizing their potential role in diagnostics and prognostics. Researchers will share insights into how organoid-derived biomarkers can enhance patient stratification.

Track 11

Future Directions in Organoid Research

This track will explore emerging trends and future directions in organoid research, including novel applications and interdisciplinary collaborations. Participants will discuss the potential impact of technological advancements on the field of organoid research.